To this end, it is noted that next‐generation sequencing is important for patient stratification, since it can screen not only for variants in known ALS genes but also in other ALS related genes, such as gene modifiers or drug metabolism‐related genes like the CYP1A2. This evidence concerns the gene CYP1A2 and amyotrophic lateral sclerosis.